Loading menu…

Tattoo as a Possible Trigger for Autoimmune Syndrome Induced by Adjuvants

Tattoo as a Possible Trigger for Autoimmune Syndrome Induced by Adjuvants

Article Fingerprint

ReserarchID

6558G

Tattoo as a Possible Trigger for Autoimmune Syndrome Induced by Adjuvants Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Reading Preferences
Font Size
Line Spacing
Background
This converted HTML version may contain rendering inconsistencies. Please refer to the PDF for the authoritative version, or click here to provide feedback.

Abstract

Autoimmune/Inflammatory Syndromes Induced by Adjuvants (ASIA) syndrome is a group of immune-mediated disorders and symptoms that may appear in genetically predisposed individuals after environmental exposure to external factors, the adjuvants, such as silicone, aluminium and other metals. Sarcoidosis, one of its classic examples, have been previously described following tattoo. However, tattoo ink is still not recognized as one of the adjuvants capable of triggering the ASIA syndrome. To reinforce our theory, we also described a 32-yearold patient that developed arthralgia, sicca syndrome, small fiber neuropathy, and post orthostatic tachycardia syndrome (POTS) after being exposed to extensive areas of tattoos and propose the tattoo ink as a possible trigger for the ASIA syndrome, questioning its safety in individuals genetically prone for autoimmunity.

I. INTRODUCTION

Autoimmune/Inflammatory Syndromes Induced by Adjuvants (ASIA) comprise a group of immune-mediated disorders that flourish in genetically predisposed individuals after environmental exposure to so-called adjuvants [1]. The most described adjuvants related to this syndrome include silicone (i.e. Breast silicone implants), aluminium salts, and other metals and vaccines [2–6]. The removal of these agents tend to lead to an improvement of the symptoms and reduction of the related autoantibodies levels when present [5–7]. The adjuvants are responsible for stimulating both the innate and the adaptive immune system and for activating pattern recognition receptors, increasing the immune response to non-pathological stimuli in a genetically prone subject [8].

Sarcoidosis, Sjogren's syndrome, silicone implant incompatibility, and undifferentiated connective tissue disease (UCTD) are examples of conditions that could be considered to have a common pathogenic mechanism for ASIA syndrome, in which individuals genetically prone to autoimmunity, such as those with HLADRB1 or having the PTPN22 genes, develop the disorder after being exposed to the external triggers[9-11].

II. CASE IN POINT

A 32-year-old woman presented with arthralgia in her both wrists, knees and ankles, pain in the Achilles tendon area and morning stiffness of one to two hours everyday, dry mouth and eyes, generalized fatigue, right hand and right hemifacial weakness and hyperesthesia of the right leg that appeared two months ago. She had no fever or skin rashes. Additionally, she complains of headache and blurred vision that started around four months ago, with no photophobia or nausea and vomiting, as well as tachycardia and dizziness when standing up. Her physical examination had no remarkable findings, orthostatic hypotension test was negative, but tachycardia of 125 bpm was detected during the maneuver. On her laboratory examination, she had no outstanding results, including low inflammatory phase markers on her blood and negative ANA, anti-Ro, anti-La and ANCA. Her sacral MRI shows no signs of acute or chronic sacroiliitis or findings compatible with spondyloarthritis, her regular and angio-CT of the head were normal, as well as lumbar puncture (LP). On her brain MRI there was no acute findings, and she was treated with IV hydration and caffeine with partial response. To evaluate her peripheral neurological complaints, a Nerve Conduction Study Electromyogram (NCS-EMG) was performed showing a decreased sympathetic response on her right foot and normal on her right hand, with no signs of large fiber polyneuropathy or radiculopathy, that may be compatible with small fiber neuropathy, requiring a skin biopsy for confirmation. When looking for circulating autoantibodies against G protein-coupled receptors of the autonomic nervous system, she had high levels of antibodies against beta1adrenergic receptor, Beta 2 adrenergic receptor and M3 acetylcholine receptor.

On her medical background, she had a previous diagnosis of Crohn's disease (CD), made two years ago, when she had fatigue, generalized arthralgia and diarrhea, positive Anti-saccharomyces cerevisiae antibodies, colonoscopy and capsule endoscopy with signs of inflammation in the terminal ileum and confirming biopsy for CD. At the time, it was started treatment with Prednisone 40 mg, with partial improvement. Biological therapy with Vedolizumab was recommended, but the patient refused the treatment. She had no CD symptoms until four months ago when she had disease flare with diarrhea and abdominal pain, treated with steroids. In addition to CD, her past medical history is positive for depression and anxiety, treated with selective serotonin receptor inhibitor, endometriosis and deep venous thrombosis in her right arm in 2017, treated with clexane for three months.

The patient works as a tattoo artist and has personally done extensive tattoos on her own (Fig. 1-4). Before her tattoos, she had no symptoms.

a) Aluminium and other metals and tattoo

Interestingly, aluminium salts and other metals were described as components of different colors of tattoo ink [30]. Specifically, the aluminium salts were described as ingredients of the violet ink. Our patient, that had no symptoms previous to her fist tattoo, has various and extensive tattoos, including some with violet ink (Fg. 1-4). The presence of aluminium in ink could explain the mechanism through which tattoo may lead to ASIA syndrome, as observed in the described patient.

b) Sjogren's syndrome and Tattoo

Sjogren's syndrome (SS) is an autoimmune condition in which salivary and lacrimal glands inflammation lead to a glandular dysfunction, resulting clinically in dry eyes and mouth and commonly other extra-glandular manifestations, including arthralgia [12]. It can be primary or secondary to other autoimmune conditions, such as rheumatoid arthritis [12]. Our patient presented to us with generalized arthralgia, as well as dry mouth and eyes with a positive Schirmer test. Even though SS is considered one of the classic examples of ASIA syndrome[9], there are no reports in the literature that associate those symptoms with the presence of tattoo pigments. Sarcoidosis, on the other hand, another classic manifestation of ASIA syndrome, had been previously associated with the presence of tattoos[13-15].

c) Sarcoidosis and Tattoo

Sarcoidosis is a systemic granulomatous pathology of still unclear etiology that develops when a prone individual is exposed to an antigen capable of inducing Th1 immune response and consequent granuloma formation in different organs, including mainly the lungs and lymph-nodes [16]. Infections, autoantigens and inorganic compounds were already described as common triggers[17]. A 29-year-old man had been reported to develop systemic sarcoidosis after tattoo. He had pleuritic chest pain, dyspnoea and cough. On physical examination, there were papules over his tattoo areas and bilateral basal crackles on lung auscultation. Chest X-ray showed bilateral lymphadenopathy and reticulonodular opacities. In the skin biopsy, noncaseating granulomas with black tattoo pigments were observed[15].

Systemic sarcoidosis and granulomatous reaction without sarcoidosis were previously described in more than 30 patients following permanent tattoo, in the presence or absence of uveitis [13]. It is well known that sarcoidosis granulomas tend to develop in previous scars sites, explaining the finding of granulomas in the tattoo areas in those patients [15]. Interestingly, three tattooed patients were described with isolated eye inflammation, which included posterior uveitis, panuveitis and retinal vasculitis, without other manifestations or granuloma formation elsewhere [18–20]. This may suggest that tattoo ink contains a specific antigen that could stimulate the immune response, locally seen by granuloma formation in the tattoo area or other systemic inflammatory manifestations such as uveitis. A vitreous biopsy performed in a patient with tattoo-associated uveitis showed no tattoo pigment or granulomas, but infiltration of T-lymphocytes with atypia, supporting the explanation of this symptom occurring due to an autoinflammatory/immune reaction [21].

d) Post Orthostatic Tachycardia syndrome, ASIA syndrome and tattoo

Our patient also presented with tachycardia and dizziness when standing up. Post-orthostatic Tachycardia syndrome (POTS) is a clinical condition in which patients present with tachycardia and discomfort symptoms when assuming the orthostatic position, without hypotension. The orthostatic tachycardia is described as an elevation of 30 bpm from the heart rate measured before standing or maintaining the heart rate, within 10 minutes of standing, superior of 120bpm[22]. The symptoms include palpitations, lightheadedness, blurred vision, generalized weakness, fatigue, among others. The physiopathology of POTS combines multiple and coexistent mechanisms, such as autonomic denervation, hypovolemia and hyperadrenergic stimulation [23]. Although its etiology remains unclear, many studies had recently supported the hypothesis of it being an autoimmune disease[24]. The central argument for this hypothesis is the finding of autoantibodies in POTS patients' sera. These antibodies mainly target G-coupled proteins, including muscarinic, nicotinic and adrenergic receptors[24–27]. POTS was previously associated with small fiber neuropathy and, thus, may also be a part of ASIA syndrome. In Germany, C fiber involvement was observed in 45% of the 84 patients with POTS analyzed – and the reduced density of those fibers was correlated with a decreased adrenergic cardiac 123 l-metaiodobenzylguanadine (MIBG) uptake – suggesting an association between the small fiber neuropathy and the reduced myocardial postganglionic sympathetic innervation that could explain the abnormal tachycardia in those patients[28]. Other researchers looked for the correlation between

POTS and SFN. It was found that 20% of POTS patients' skin biopsy had signs of SFN[29].

e) Similarities between Silicone Incompatibility Syndrome and ASIA syndrome following tattoo

Recently, silicone breast implants were associated with the development of many general symptoms, for example, sleep disturbances, general fatigue, generalized pain, depression, hair loss, among others [9]. It has been proposed that those symptoms may relate to an autoimmune neurosensory dysautonomia, involving autoantibodies against G-protein coupled receptors of the autonomic nervous system such as the adrenergic and endothelin and angiotensin ones, which may result in small fiber neuropathy in a subgroup of these women [31]. Similarly, our patient had depression, anxiety and multiple neurologic complaints with an NCS-EMG showing decreased sympathetic response on her right foot, with no signs of large fiber polyneuropathy.

As for the above mentioned, autonomic-related manifestations (POTS, sicca syndrome, paresthesia and other signs of small fiber neuropathy) reported by our patient, we hypothesized the potential involvement of autoantibodies against GPCRs of the autonomic nervous system. These functional antibodies have already been described to be involved in the development of autoimmune diseases and other suspected immune- and dysautonomic-related disorders (such as Sjögren's syndrome, RA, SLE, MS, myasthenia gravis, POTS etc.[32–38]) and were found to be dysregulated in women with SBIs as well (Submitted/Personal communication). Indeed, we found increased circulation levels of anti-beta1, anti-beta2 and anti-M3 AAbs in our patient as compared to the normal ranges in healthy women, which might play a role in the appearance of autonomic-related symptoms in our patient.

f) Potential therapies for ASIA syndrome following tattoo

Some cases of ASIA syndrome had also been described following injection of S.C. methylmetacrylate [39–41]. Methylmetacylate S.C. injections have been used in the last decades mainly with aesthetic goals in different body areas, from the lips to the buttocks. It has been recently proposed to treat those patients with intralesional neodymium laser [42]. Intralesional laser technique has been largely used as well for tattoo removal [43,44]. As previously mentioned, frequently, in ASIA syndrome, the removal of the adjuvant exposure may ameliorate the signs and symptom of the disease. Extraction of silicone implants, for instance, was shown to improve the symptoms such as fatigue, arthralgia and sicca syndrome [45]. Hence, tattoo laser removal could be a potential treatment option for those patients.

III. CONCLUSION

In this review, we raise the hypothesis of tattoo pigment as a new component of the group of adjuvants that trigger ASIA syndrome and question its safety in individuals genetically prone to develop autoimmunity. To reinforce our proposal, we described a 32-year-old woman with known Chron's disease that presented with arthralgia, morning stiffness, dry mouth and eyes, POTS and neurological complaints compatible with small fiber neuropathy after exposure to an extensive tattoo pigmentation (Fg 1-4). Although those symptoms had not been previously associated with the presence of tattoo ink, permanent tattoos had been previously linked to sarcoidosis and isolated uveitis [15, 46]. In addition, those symptoms have been related to other environmental exposures, such as to aluminium, other metals, silicone and vaccines [1, 6, 7, 9, 47]. In fact, some of the tattoo inks have been demonstrated to contain aluminum [30]. Moreover, removing the adjuvants had been shown to improve the clinical presentation and the laboratory markers in ASIA syndrome [9]. Tattoo removal with laser technique could be a potential solution for ASIA syndrome following tattoo.

ACKNOWLEDGMENT

We would like to express our acknowledgment to Yaron and Dina Shamia for their support.

Figures 1-4: Images from our patient's extensive tattoos.
Figures 1-4: Images from our patient's extensive tattoos.

References

47 Cites in Article
  1. 1. Y Shoenfeld,N Agmon-Levin (2011). ASIA"autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun, 36, 4-8.
  2. 2. V Molina,Y Shoenfeld (2005). Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity, 38, 235-245.
  3. 3. R Inbar,R Weiss,L Tomljenovic,M-T Arango,Y Deri,C Shaw,J Chapman,M Blank,Y Shoenfeld (2017). Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil. Immunol Res, 65, 136-149.
  4. 4. Agmon-Levin Nancy,Yehuda Shoenfeld (2008). Chronic fatigue syndrome with autoantibodies — The result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmunity Reviews, 8(1), 52-55.
  5. 5. P Kagan,G Halpert,H Amital,R Shapira,Y Shoenfeld (2020). Autoimmune/Inflammatory Syndrome Induced by Adjuvant Associated with a Metal Implant in the Mouth; Explantation Was Followed by Recovery. Isr Med Assoc J, 9, 516-517.
  6. 6. Ariel Schiff,Nizar Jiries,Shaul Goldsztein,Elad Schiff,Shira Ginsberg (2020). A possible association of orthopedic metal implants and ASIA syndrome. Rheumatology, 60(3), e95-e96.
  7. 7. Abdulla Watad,Kassem Sharif,Yehuda Shoenfeld (2017). The ASIA syndrome: basic concepts. Mediterranean Journal of Rheumatology, 28(2), 64-69.
  8. 8. A Watad,M Quaresma,S Brown,J Cohen Tervaert,I Rodríguez-Pint,R Cervera,C Perricone,Y Shoenfeld (2017). Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome) – An update. Lupus, 26(7), 675-681.
  9. 9. Vânia Borba,Anna Malkova,Natalia Basantsova,Gilad Halpert,Laura Andreoli,Angela Tincani,Howard Amital,Yehuda Shoenfeld (2020). Classical Examples of the Concept of the ASIA Syndrome. Biomolecules, 10(10), 1436.
  10. 10. Jorge Cárdenas-Roldán,Adriana Rojas-Villarraga,Juan-Manuel Anaya (2013). How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Medicine, 11(1), 73.
  11. 11. Sophie Steiner,Sonya Becker,Jelka Hartwig,Franziska Sotzny,Sebastian Lorenz,Sandra Bauer,Madlen Löbel,Anna Stittrich,Patricia Grabowski,Carmen Scheibenbogen (2020). Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset. Frontiers in Immunology, 11, 578.
  12. 12. Xavier Mariette,Lindsey Criswell (2018). Primary Sjögren’s Syndrome. New England Journal of Medicine, 378(10), 931-939.
  13. 13. N Kluger (2018). Tattoo‐associated uveitis with or without systemic sarcoidosis: a comparative review of the literature. Journal of the European Academy of Dermatology and Venereology, 32(11), 1852-1861.
  14. 14. Koichi Izumikawa,Noriko Motoi,Hisashi Takaya,Atsushi Miyamoto,Yoshinobu Eishi,Kunihiko Yoshimura,Kazuma Kishi (2011). A Case of Concurrent Sarcoidosis, Aortitis Syndrome and Crohn's Disease. Internal Medicine, 50(23), 2915-2917.
  15. 15. L Torres,S Faiz (2014). Tattoos and Sarcoidosis. N Engl J Med, 370, 34.
  16. 16. Sara Bindoli,A Dagan,J Torres-Ruiz,C Perricone,M Bizjak,Doria Shoenfeld,Y (2016). SARCOIDOSIS AND AUTOIMMUNITY: FROM GENETIC BACKGROUND TO ENVIRONMENTAL FACTORS. Isr Med Assoc J, 18, 197-202.
  17. 17. Dominique Valeyre,Antje Prasse,Hilario Nunes,Yurdagul Uzunhan,Pierre-Yves Brillet,Joachim Müller-Quernheim (2014). Sarcoidosis. The Lancet, 383(9923), 1155-1167.
  18. 18. J Orellana Rios,J Verdaguer Díaz,J Agee,R Theodore Smith (2018). Tattoo associated retinochoroiditis. Archivos de la Sociedad Española de Oftalmología (English Edition), 93(4), 193-197.
  19. 19. Aneta Klímová,Michaela Brichová,Eva Říhová,Jarmila Heissigerová,Petra Svozílková (2017). Immune-Mediated Intraocular Inflammation. Review. Czech and Slovak Ophthalmology, 77(4), 163-168.
  20. 20. M Moschos,Y Guex-Crosier (2004). Retinal Vasculitis and Cystoid Macular Edema after Body Tattooing: a Case Report. Klinische Monatsblätter für Augenheilkunde, 221(05), 424-426.
  21. 21. Ashvini Reddy,Yevgeniy Shildkrot,Steven Newman,Jennifer Thorne (2015). T-Lymphocyte Predominance and Cellular Atypia in Tattoo-Associated Uveitis. JAMA Ophthalmology, 133(11), 1356.
  22. 22. R Sheldon,Grubb Bp 2nd,B Olshansky (2015). 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Hear Rhythm, 12, 41-63.
  23. 23. Eduardo Benarroch (2012). Postural Tachycardia Syndrome: A Heterogeneous and Multifactorial Disorder. Mayo Clinic Proceedings, 87(12), 1214-1225.
  24. 24. Hongliang Li,Xichun Yu,Campbell Liles,Muneer Khan,Megan Vanderlinde‐wood,Allison Galloway,Caitlin Zillner,Alexandria Benbrook,Sean Reim,Daniel Collier,Michael Hill,Satish Raj,Luis Okamoto,Madeleine Cunningham,Christopher Aston,David Kem (2014). Autoimmune Basis for Postural Tachycardia Syndrome. Journal of the American Heart Association, 3(1), 755.
  25. 25. W Gunning 3rd,H Kvale,P Kramer,B Karabin,B Grubb (2019). Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies. J Am Heart Assoc, 8, 13602-e13602.
  26. 26. Artur Fedorowski,Hongliang Li,Xichun Yu,Kristi Koelsch,Valerie Harris,Campbell Liles,Taylor Murphy,Syed Quadri,Robert Scofield,Richard Sutton,Olle Melander,David Kem (2017). Antiadrenergic autoimmunity in postural tachycardia syndrome. EP Europace, 19(7), 1211-1219.
  27. 27. D Dubey,S Hopkins,S Vernino (2016). M1 and M2 muscarinic receptor antibodies among patients with postural orthostatic tachycardia syndrome: potential disease biomarker. J Clin Neuromuscul Dis, 17, 179S.
  28. 28. Carl‐albrecht Haensch,Marco Tosch,Istvan Katona,Joachim Weis,Stefan Isenmann (2014). Small‐fiber neuropathy with cardiac denervation in postural tachycardia syndrome. Muscle & Nerve, 50(6), 956-961.
  29. 29. V Iodice,D Low,C Mathias,P Facer,Y Yiangou,P Anand (2015). Small fibre neuropathy and collagen IV reduction in postural tachycardia syndrome and joint hypermobility syndrome. Auton Neurosci, 192, 125.
  30. 30. Parvez Islam,Christopher Chang,Carlo Selmi,Elena Generali,Arthur Huntley,Suzanne Teuber,M Gershwin (2016). Medical Complications of Tattoos: A Comprehensive Review. Clinical Reviews in Allergy & Immunology, 50(2), 273-286.
  31. 31. Yehuda Shoenfeld,Varvara Ryabkova,Carmen Scheibenbogen,Louise Brinth,Manuel Martinez-Lavin,Shuichi Ikeda,Harald Heidecke,Abdulla Watad,Nicola Bragazzi,Joab Chapman,Leonid Churilov,Howard Amital (2020). Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clinical Immunology, 214, 108384.
  32. 32. Kyungpyo Park,Rainer Haberberger,Tom Gordon,Michael Jackson (2011). Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome. Arthritis & Rheumatism, 63(5), 1426-1434.
  33. 33. O Malysheva,M Pierer,U Wagner,M Wahle,U Wagner,C Baerwald (2008). Association between β2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope. Annals of the Rheumatic Diseases, 67(12), 1759-1764.
  34. 34. Krystian Jazdzewski,Tomasz Bednarczuk,Magdalena Stepnowska,Sandya Liyanarachchi,Krystyna Suchecka-Rachon,Janusz Limon,Krzysztof Narkiewicz (2007). β-2-Adrenergic receptor gene polymorphism confers susceptibility to Graves disease. International Journal of Molecular Medicine, 19, 181-186.
  35. 35. J V Metcalf,R Bhopal,J Gray,D Howel,O James (1997). Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. International Journal of Epidemiology, 26(4), 830-836.
  36. 36. Otavio Cabral-Marques,Alexandre Marques,Lasse Giil,Roberta De Vito,Judith Rademacher,Jeannine Günther,Tanja Lange,Jens Humrich,Sebastian Klapa,Susanne Schinke,Lena Schimke,Gabriele Marschner,Silke Pitann,Sabine Adler,Ralf Dechend,Dominik Müller,Ioana Braicu,Jalid Sehouli,Kai Schulze-Forster,Tobias Trippel,Carmen Scheibenbogen,Annetine Staff,Peter Mertens,Madlen Löbel,Justin Mastroianni,Corinna Plattfaut,Frank Gieseler,Duska Dragun,Barbara Engelhardt,Maria Fernandez-Cabezudo,Hans Ochs,Basel Al-Ramadi,Peter Lamprecht,Antje Mueller,Harald Heidecke,Gabriela Riemekasten (2018). GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis. Nature Communications, 9(1), 5224.
  37. 37. B Xu,D Huang,R Pirskanen,A Lefvert (2000). beta2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG). Clin Exp Immunol, 119, 156-160.
  38. 38. Anthony Smith,Michael Jackson,Fang Wang,Dana Cavill,Maureen Rischmueller,Tom Gordon (2005). Neutralization of Muscarinic Receptor Autoantibodies by Intravenous Immunoglobulin in Sjögren Syndrome. Human Immunology, 66(4), 411-416.
  39. 39. Olga Vera-Lastra,Eduardo Rojas-Milán,Ana Peralta-Amaro,Magdalena Sánchez-Uribe,Leopoldo Cruz-González,Mario Hernández-Sánchez,Laura Tecayehuatl-Negrete,María Cruz-Dominguez,Luis Jara (2020). Autoimmune/inflammatory syndrome induced by methylmethacrylate associated to seronegative antiphospholipid syndrome and diffuse large B-cell non-Hodgkin’s lymphoma. Lupus, 29(10), 1292-1296.
  40. 40. Alberto Goldman,Uwe Wollina (2019). Polymethylmethacrylate-induced nodules of the lips: Clinical presentation and management by intralesional neodymium:YAG laser therapy. Dermatologic Therapy, 32(1), e12755.
  41. 41. A Goldman,H Staub,U Wollina (2018). HYPERCALCEMIA DUE TO POLYMETHYLMETHACRYLATE INJECTIONS? (LITERATURE REVIEW AND CASE REPORTS). Georgian Med News, 17-20.
  42. 42. Alberto Goldman,Uwe Wollina (2018). Intralesional Neodymium YAG laser to Treat Complications of Polymethylmethacrylate. Open Access Macedonian Journal of Medical Sciences, 6(9), 1636-1641.
  43. 43. Keun Ahn,Zhenlong Zheng,Tae Kwon,Beom Kim,Hye Lee,Sung Cho (2017). Pattern analysis of laser-tattoo interactions for picosecond- and nanosecond-domain 1,064-nm neodymium-doped yttrium-aluminum-garnet lasers in tissue-mimicking phantom. Scientific Reports, 7(1), 1533.
  44. 44. N Khunger,A Molpariya,A Khunger (2015). Complications of Tattoos and Tattoo Removal: Stop and Think Before you ink. J Cutan Aesthet Surg, 8, 30-36.
  45. 45. Maartje Colaris,Mintsje De Boer,Rene Van Der Hulst,Jan Cohen Tervaert (2017). Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature. Immunologic Research, 65(1), 120-128.
  46. 46. Trucian Ostheimer,Bryn Burkholder,Theresa Leung,Nicholas Butler,James Dunn,Jennifer Thorne (2014). Tattoo-Associated Uveitis. American Journal of Ophthalmology, 158(3), 637-643.e1.
  47. 47. Luísa Guimarães,Britain Baker,Carlo Perricone,Yehuda Shoenfeld (2015). Vaccines, adjuvants and autoimmunity. Pharmacological Research, 100, 190-209.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Paula David, Abdulla Watad, Gilad Halpert, Yehuda Shoenfeld. 2021. "Tattoo as a Possible Trigger for Autoimmune Syndrome Induced by Adjuvants". Global Journal of Medical Research - F: Diseases GJMR-F Volume 21 (GJMR Volume 21 Issue F1).

More Citation Formats

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-F Classification NLMC Code: WD 305
Version of record
v1.2

Issue date
March 28, 2021

Language
English
Order Article Reprint
Experience in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 799
Total Downloads: 50
All Trends

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Tattoo as a Possible Trigger for Autoimmune Syndrome Induced by Adjuvants

Paula David
Paula David
Abdulla Watad
Abdulla Watad
Gilad Halpert
Gilad Halpert
Yehuda Shoenfeld
Yehuda Shoenfeld